The ubiquitin/proteasome-dependent proteolytic pathway is an attractive target for therapeutics because of its critical involvement in cell cycle progression and antigen presentation. However, ...
To efficiently infect target cells, human immunodeficiency virus (HIV)-1 requires CD4 together with a specific chemokine co-receptor 1. In vivo, the chemokine receptor CCR5 is central to the ...